PALBOCICLIB IN THE DAILY CLINICAL USE: REAL EXPERIENCE IN METASTATIC BREAST CANCER IN OUR INSTITUTION

被引：1
|
作者：
Mainella, A. [1 ]
Marmissolle, F. [1 ]
Vigo, S. [1 ]
Price, P. [1 ]
Sansano, M. [1 ]
Lujan, M. L. [1 ]
Dominguez, Mp [1 ]
Caamano, G. Zapata [1 ]
Menna, E. [1 ]
Giacomi, N. [1 ]
机构：
[1] COI La Plata, Ctr Oncol Integral, La Plata, Argentina
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷
关键词：
D O I：
10.1136/ijgc-2020-IGCS.207
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS20_124
引用
收藏
页码：A98 / A99
页数：2
相关论文
共 50 条
  • [31] The safety and efficacy of palbociclib in the treatment of metastatic breast cancer
    Ettl, Johannes
    Harbeck, Nadia
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (08) : 661 - 668
  • [32] Metastatic HR+/HER2-Breast Cancer Real-World Data support the clinical Benefits of Palbociclib
    Schoellmann, Claudia
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (1-2)
  • [33] Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
    Adam Brufsky
    Xianchen Liu
    Benjamin Li
    Lynn McRoy
    Rachel M. Layman
    Targeted Oncology, 2021, 16 : 601 - 611
  • [34] Comparative effectiveness of palbociclib plus letrozole vs letrozole for metastatic breast cancer in US real-world clinical practices
    Layman, R. M.
    Liu, X.
    Mardekian, J.
    McRoy, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 115 - +
  • [35] Real-World Tumor Response of Palbociclib Plus Letrozole Versus Letrozole for Metastatic Breast Cancer in US Clinical Practice
    Brufsky, Adam
    Liu, Xianchen
    Li, Benjamin
    McRoy, Lynn
    Layman, Rachel M.
    TARGETED ONCOLOGY, 2021, 16 (05) : 601 - 611
  • [36] Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer
    Wilkie, Jonathan
    Schickli, M. Alexandra
    Berger, Michael J.
    Lustberg, Maryam
    Reinbolt, Raquel
    Noonan, Anne
    Ramaswamy, Bhuvaneswari
    Sardesai, Sagar
    VanDeusen, Jeffrey
    Wesolowski, Robert
    Williams, Nicole
    Stover, Daniel G.
    Li, Junan
    Vargo, Craig A.
    CLINICAL BREAST CANCER, 2020, 20 (01) : 33 - 40
  • [37] Real-world tumour response of palbociclib plus letrozole vs letrozole for metastatic breast cancer in US clinical practices
    Brufsky, A.
    Liu, X.
    Li, B.
    Mcroy, L.
    Layman, R. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S79 - S79
  • [38] Real world clinical outcomes of palbociclib in hormone receptor positive (HR plus ) metastatic breast cancer (MBC) patients.
    Eziokwu, Akaolisa Samuel
    Varella, Leticia
    Kruse, Megan Lynn
    Jia, Xuefei
    Moore, Halle C. F.
    Budd, George Thomas
    Abraham, Jame
    Montero, Alberto J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Treatment and outcome of metastatic breast cancer (MBC) patients in our institution: A retrospective study
    Ratti, Riccardo
    Sburlati, Paola
    Farina, Gabriella
    La Verde, Nicla
    Pedretti, Donata
    Bianchi, Celso
    Rovej, Rossella
    Cobelli, Stefano
    Mantica, Cristina
    Scanni, Alberto
    ANNALS OF ONCOLOGY, 2005, 16 : 15 - 16
  • [40] HER2 LOW METASTATIC BREAST CANCER PATHOLOGICAL AND CLINICAL CHARACTERISTICS: A SINGLE MEXICAN INSTITUTION EXPERIENCE
    Tereza Nieto-Coronel, Maria
    Arce-Salinas, Claudia
    Tabares-Nanez, Ariana
    Curigliano, Giuseppe
    BREAST, 2023, 71 : S48 - S48
12345